Searched for
REDDYS LABORATORIES LTD HYDERABAD
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- El Nino fear pushes farmers in Srikakulam and Vizianagaram towards water-saving paddy methodsFarmers in Andhra Pradesh's Srikakulam and Vizianagaram districts are shifting to water-saving rice farming techniques. Facing potential El...
- Three returnees from Ebola-hit African countries quarantined in Durg: Chhattisgarh Health Minister Shyam JaiswalChhattisgarh is fully prepared for potential virus infections. Health Minister Shyam Bihari Jaiswal assured that hospitals and quarantine f...
- Stocks in news: ITC, Nykaa, Lenskart, Ola Electric, IndusInd BankMarkets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downsid...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Reddy Pharma loses 'name' in Delhi HC rulingThe Delhi High Court has ruled against Reddy Pharmaceuticals. The court upheld a decision to remove 'Reddy' from the company's name. Reddy ...
- Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business press...
- Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....
- Dr Reddy’s Laboratories receives approval from Health Canada for its generic semaglutide injectionDr Reddy's Laboratories has achieved a significant milestone. Health Canada has approved its generic semaglutide injection. This makes Dr R...
- Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging errorDr Reddy's Laboratories is recalling over 8,000 bottles of Tacrolimus capsules from the US market due to a packaging error. The Hyderabad-b...
- Dr Reddy's to enhance presence in emerging segments like nutraceuticals, gene therapyDr Reddy's Laboratories plans to expand its presence in nutraceuticals, cell and gene therapy and new chemical entities, as well as explori...
- Centre sanctions funds from PMCares for new vaccine-testing labThe increased focus on vaccine production against the backdrop of COVID-19 pandemic has necessitated more vaccine- testing laboratories in ...
- Dr Reddy's gets EIR for 2 facilitiesThe company has received EIR from USFDA for its formulations manufacturing facility at Srikakulam unit II, Dr Reddy's said in a filing to B...
- Dr Reddy's gets 11 observations from USFDA for Hyderabad plantThe audit of our formulations manufacturing plant-3 at Bachupally, Hyderabad by the USFDA has been completed today, said Dr Reddy's Lab.
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Andhra Pradesh government lifts 6-year-old ban on bulk-drug plantsAndhra Pradesh government has lifted a ban on the expansion of bulk drug manufacturing facilities imposed six years ago to curb pollution.
- Two killed after inhaling gas at Dr Reddy's LabTwo workers of the drug firm Dr Reddy's Laboratories lost their lives and two others fell unconscious in an accidental gas leak this mornin...
- Dr Reddy's scrip hits month low on BSE; slips over 4 pcA gas leakage happened in the Dr Reddy's Hyderabad plant today, in which two employees of the company have lost their lives.
- Entrepreneurship bug bites pharma, biotech execsSenior professionals have earned enough expertise to start their own ventures at a time when the market and funding options are favourable.
- Pillion ride to etrepreneurshipProfessionals in pharma and biotechnology companies are increasingly taking the plunge to set up start-ups - a trend which investors descri...
Load More
